Literature DB >> 10548573

Comparative analysis of two meningococcal immunotyping monoclonal antibodies by resonant mirror biosensor and antibody gene sequencing.

B M Charalambous1, J Evans, I M Feavers, M C Maiden.   

Abstract

Lipooligosaccharide (LOS) is a major surface component of the cell walls of Neisseria meningitidis, which is important for its roles in pathogenesis and antigenic variation, as a target for immunological typing, and as a possible vaccine component. Although the structures of many antigenic variants have been determined, routine immunological typing of these molecules remains problematic. Resonant mirror analysis was combined with gene sequencing to characterize two monoclonal antibodies (MAbs) used in typing panels that were raised against the same LOS immunotype, L3,7,9. The two MAbs (MAb 4A8-B2 and MAb 9-2-L379) were of the same immunoglobulin subtype, but while MAb 9-2-L379 was more than a 1,000-fold more sensitive in immunotyping assays of both whole meningococcal cells and purified LOS, MAb 4A8-B2 was more specific for immunotype L3,7,9. The differences in sensitivity were a consequence of MAb 9-2-L379 having a 44-fold-faster association constant than MAb 4A8-B2. Comparison of the amino acid sequences of the variable chains of the MAbs revealed that they had very similar heavy chains (81% amino acid sequence identity) but diverse light chains (54% sequence identity). The differential binding kinetics and specificities observed with these MAbs were probably due to differences in the epitopes recognized, and these were probably a consequence of the different immunization protocols used in their production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548573      PMCID: PMC95785          DOI: 10.1128/CDLI.6.6.838-843.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  21 in total

Review 1.  Surface plasmon resonance biosensors as a tool in antibody engineering.

Authors:  K Alfthan
Journal:  Biosens Bioelectron       Date:  1998-09-15       Impact factor: 10.618

2.  Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.

Authors:  F Michon; M Beurret; A Gamian; J R Brisson; H J Jennings
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

Review 3.  The lipooligosaccharides of pathogenic gram-negative bacteria.

Authors:  A Preston; R E Mandrell; B W Gibson; M A Apicella
Journal:  Crit Rev Microbiol       Date:  1996       Impact factor: 7.624

4.  Purification of meningococcal lipo-oligosaccharide by FPLC techniques.

Authors:  J S Evans; M C J Maiden
Journal:  Microbiology (Reading)       Date:  1996-01       Impact factor: 2.777

Review 5.  Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease.

Authors:  A P Moran; M M Prendergast; B J Appelmelk
Journal:  FEMS Immunol Med Microbiol       Date:  1996-12-01

6.  The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis.

Authors:  H J Jennings; K G Johnson; L Kenne
Journal:  Carbohydr Res       Date:  1983-09-16       Impact factor: 2.104

Review 7.  Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin).

Authors:  C M Kahler; D S Stephens
Journal:  Crit Rev Microbiol       Date:  1998       Impact factor: 7.624

8.  Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Authors:  A F Verheul; A K Braat; J M Leenhouts; P Hoogerhout; J T Poolman; H Snippe; J Verhoef
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation.

Authors:  N S Young; J Levin; R A Prendergast
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

10.  Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.